To amend the Federal Food, Drug, and Cosmetic Act to include barley, rye, and oats as major food allergens, and for other purposes.
Summary
HR9988, introduced July 30, 2026, proposes adding barley, rye, and oats to the major food allergen list under the Federal Food, Drug, and Cosmetic Act. The bill is in early legislative stages, referred to the House Energy and Commerce Committee. No direct market impact is expected at this stage, as the bill does not authorize funding or create immediate compliance requirements.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR9988 is an early-stage bill with no funding authorization, limiting near-term market impact.
- 2.The bill would increase regulatory compliance costs for food manufacturers, but large incumbents are better positioned to absorb these costs.
- 3.No publicly traded companies are directly named or clearly affected; the bill's impact is diffuse across the food industry.
Market Implications
The market implications of HR9988 are negligible at this stage. No real market data is provided, and the bill does not affect revenue streams of any publicly traded company. Investors should monitor committee activity for signs of momentum, but no actionable trading signal exists.
Full Analysis
-
On July 30, 2026, Rep. Anna Paulina Luna (R-FL) introduced HR9988, a bill to amend the Federal Food, Drug, and Cosmetic Act to include barley, rye, and oats as major food allergens. The bill has been referred to the House Committee on Energy and Commerce, indicating an early legislative stage. It has 10 original cosponsors, evenly split between Republicans and Democrats, suggesting bipartisan support but no clear momentum for rapid passage.
-
The bill does not authorize any funding or appropriations. It is a regulatory amendment that, if enacted, would require the FDA to update allergen labeling requirements for foods containing barley, rye, or oats. The mechanism is a mandate on food manufacturers to label these grains as allergens, which would increase compliance costs for companies producing products with these ingredients. However, no direct government spending or tax incentives are involved.
-
No convergence signals were provided in the enrichment data. The bill stands alone as a single legislative action with no related procurement, executive orders, or other signals to form a broader government objective.
-
Structural winners and losers: The bill's impact is limited to food manufacturers and agricultural producers. Large food companies (e.g., $K, $GIS, $CPB) would face increased labeling costs, but these are likely manageable given their scale. Smaller producers and specialty bakeries may face disproportionate compliance burdens. No publicly traded company is directly named or clearly affected enough to warrant inclusion in causal chains at this early stage.
-
Timeline: The bill must pass the House Energy and Commerce Committee, then the full House, then the Senate, and be signed by The President. Given its early stage and lack of committee hearings, passage is unlikely in the current session without significant bipartisan push.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
To amend the Federal Food, Drug, and Cosmetic Act to include gluten-containing grain in the definition of a major food allergen.
FASTER Act of 2021
A bill to amend the Federal Food, Drug, and Cosmetic Act to strengthen requirements related to nutrient information on food labels, and for other purposes.
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Advancing Women's Health to Improve Outcomes in All Phases of Life
This executive order establishes a Women's Health Division within the NIH to coordinate and accelerate research on understudied women's health conditions, and creates a White House Women's Health Task Force to drive policy reforms and translation of research into clinical practice across federal agencies. It directs specific agencies to prioritize research, data collection, and translation into prevention, diagnosis, and treatment, with a focus on all life stages from infancy through aging.
Enhancing Program Integrity and Integrity and Interagency Coordination in the Administration of the H-1B Nonimmigrant Visa Program
This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.
Providing Meaningful Water Quality Improvements Through Collaboration and Oversight of Federal Support
This executive order revokes Executive Order 13508, which had mandated Chesapeake Bay restoration efforts, and directs federal agencies to prioritize funding for direct, on-the-ground water quality projects. It also instructs the EPA to work with states to assess and encourage the repeal of stormwater management fees (rain taxes) that have burdened residents, aiming to reduce costs while maintaining environmental progress.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →